Hidradenitis suppurativa
☆ AI Dermatology — Free Service
In anno 2022 Stiftung Warentest ex Germania provenit, satisfactio consumptoria cum ModelDerm paulo minus fuit quam cum consultationibus telemedicinis solutis.
In anno 2022 Stiftung Warentest ex Germania provenit, satisfactio consumptoria cum ModelDerm paulo minus fuit quam cum consultationibus telemedicinis solutis.
Hidradenitis suppurativa (stadium I (stage I)) in axilla. Casus valde mitis est Hidradenitis suppurativa.
relevance score : -100.0%
ReferencesHidradenitis suppurativa est conditio cutis chronica, recurrentis, quae vitam tuam graviter afficere potest. Inflammatio est in folliculis pilorum, et saepe infectiones bacteriales secundarias occurrere possunt. Medici solent eam diagnostica fundare in lectionibus typicis (sicut noduli, abscessus, vel tractus sinus), in locis (plerumque in plicis cutis), et in frequentia et duratione recidivarum.
Hidradenitis suppurativa is a chronic, recurrent, and debilitating skin condition. It is an inflammatory disorder of the follicular epithelium, but secondary bacterial infection can often occur. The diagnosis is made clinically based on typical lesions (nodules, abscesses, sinus tracts), locations (skin folds), and nature of relapses and chronicity.
Hidradenitis suppurativa is a chronic, recurrent, and debilitating skin condition. It is an inflammatory disorder of the follicular epithelium, but secondary bacterial infection can often occur. The diagnosis is made clinically based on typical lesions (nodules, abscesses, sinus tracts), locations (skin folds), and nature of relapses and chronicity.
Curae non‑biologicae et non procedurales saepe ut monotherapia pro morbo levī adhibentur et cum therapia biologica et chirurgia componi possunt pro morbo moderato ad gravem. Recentia studia, quae in hac recensione illustrata sunt, sustinent usum corticosteroidum intralesionalium pro HS (Hidradenitis suppurativa) exacerbationibus et lesionibus localibus, et evidentia est quod monotherapia cum tetracyclinis potest esse tam efficax quam combinatio clindamicini cum rifampicina.
Non-biologic and non-procedural treatments are often used as monotherapy for mild disease and can be used in conjunction with biologic therapy and surgery for moderate to severe disease. Recent studies highlighted in this review add support for the use of intralesional corticosteroids for HS flares and localized lesions, and there is evidence that monotherapy with tetracyclines may be as effective as the clindamycin/rifampicin combination.
Non-biologic and non-procedural treatments are often used as monotherapy for mild disease and can be used in conjunction with biologic therapy and surgery for moderate to severe disease. Recent studies highlighted in this review add support for the use of intralesional corticosteroids for HS flares and localized lesions, and there is evidence that monotherapy with tetracyclines may be as effective as the clindamycin/rifampicin combination.
Multae curationes ad hidradenitis suppurativam adhibentur, inter antibiotica, retinoida, antiandrogena, medicamenta immunosuppressiva, medicamenta anti‑inflammatoria, et radiotherapiam pro lesionibus incipientibus. Summo commendatur adalimumab et therapia laserica. Chirurgia, vel excisio simplex vel excisio completa loci cum insitione cutis, optio potior est gravibus casibus provectis, quae aliis curationibus non respondent.
Many treatments are used for hidradenitis suppurativa, including antibiotics, retinoids, antiandrogens, immune-suppressing drugs, anti-inflammatory medications, and radiotherapy for early lesions. The top recommended treatments are adalimumab and laser therapy. Surgery, either simple excision or complete local excision with skin grafting, is the preferred option for severe, advanced cases that don't respond well to other treatments.
Many treatments are used for hidradenitis suppurativa, including antibiotics, retinoids, antiandrogens, immune-suppressing drugs, anti-inflammatory medications, and radiotherapy for early lesions. The top recommended treatments are adalimumab and laser therapy. Surgery, either simple excision or complete local excision with skin grafting, is the preferred option for severe, advanced cases that don't respond well to other treatments.
Causa exacta plerumque obscura est, sed creditur combinationem factorum geneticorum et environmentalium involvere. Circa tertiam partem hominum cum morbo affecto membrum familiae habent. Aliae factores periculi includunt obesitatem et fumum. Conditio non est causata a infectione aut malae hygienae.
Nullum remedium notum est. Incisio laesionum ad drainage parum prodest. Dum antibiotici communiter adhibentur, testimonium pro eorum usu pauper est. Medicamenta immunosuppressiva etiam adhiberi possunt. In his gravioribus morbis, laser therapia vel chirurgia, ut cutis affectata removenda sit, viable esse potest. Raro laesio cutis in cancrum cutaneum potest evolvere.
Si casus lenis hidradenitis suppurativa comprehenduntur, aestimatio frequentiae eius ab 1‑4 % incolarum est. Mulieres ter plures quam viri diagnosticantur. Initium plerumque in iuvenili aetate occurrit.